Feline Pyelonephritis

Feline pyelonephritis is a bacterial infection of the renal parenchyma and renal pelvis, representing the most clinically significant form of upper urinary tract infection (UTI) in cats [1]. It can present as an acute condition with overt systemic illness or as a chronic, insidious infection that may go undetected for extended periods [2]. Pyelonephritis is an important cause of acute kidney injury (AKI) and can precipitate acute decompensation in cats with pre-existing chronic kidney disease (CKD), as pyelonephritis was identified as one of the suspected etiologies for acute-on-chronic kidney disease (ACKD) in a retrospective feline cohort [4]. If left untreated or inadequately treated, the condition can lead to progressive and irreversible nephron loss, permanent renal dysfunction, and life-threatening sepsis [1][2].

Causative Organisms

The majority of feline pyelonephritis cases are caused by gram-negative bacteria, with Escherichia coli being the most commonly isolated pathogen [1][3]. Other documented causative organisms include Staphylococcus spp., Streptococcus spp., Klebsiella spp., Pseudomonas spp., Proteus spp., and Enterococcus spp. [1][2]. Fungal pyelonephritis (e.g., Candida spp.) occurs rarely, typically in immunocompromised individuals [2].

Routes of Infection

The ascending route is the most common pathway: bacteria colonize the urethra, ascend to the bladder causing cystitis, and subsequently migrate up the ureters to the renal pelvis and parenchyma [1][2]. Hematogenous seeding of the kidney from a distant focus of infection is a less common but recognized alternative route, particularly in cats with systemic bacteremia [2].

Pathophysiological Mechanism

Uropathogens overcome normal host defense mechanisms — including urine flow, urothelial barrier integrity, urine osmolality, and local immune responses — to adhere to urothelial cells via specific adhesins (e.g., type 1 and P fimbriae in E. coli) [2]. Once bacteria reach the renal pelvis, they can ascend through the collecting ducts into the renal medulla and cortex. The resulting inflammatory response triggers recruitment of neutrophils, macrophages, and cytokine release, leading to interstitial nephritis, tubular necrosis, and, in severe cases, abscess formation or papillary necrosis [1][2]. Chronic or recurrent infection results in progressive interstitial fibrosis, tubular atrophy, and permanent nephron loss, ultimately contributing to the development or progression of CKD [1][4].

Predisposing Factors

Several conditions impair local or systemic host defenses and significantly increase the risk of pyelonephritis in cats [1][3]:

• ·Pre-existing lower UTI or recurrent bacterial cystitis
• ·Urolithiasis or ureteral obstruction causing urinary stasis
• ·Perineal urethrostomy (alters normal anatomical defense barriers)
• ·Diabetes mellitus and other endocrinopathies (impaired immune function)
• ·Immunosuppressive therapy (corticosteroids, chemotherapy)
• ·Feline immunodeficiency virus (FIV) or other causes of immunosuppression
• ·Indwelling urinary catheters
• ·Pre-existing CKD (altered urine concentrating ability and local defenses)
• ·Female sex (shorter urethra facilitates ascending infection) [3]
• ·Advanced age (older cats with CKD are especially vulnerable) [3]

Diagnosis of feline pyelonephritis requires integration of clinical signs, laboratory data, and imaging findings, as no single test is definitively pathognomonic [1][2].

Clinical Assessment

History and physical examination findings such as fever, renomegaly, renal pain on palpation, and concurrent signs of systemic illness in a cat with risk factors for UTI raise strong clinical suspicion for pyelonephritis [1][2].

Urine Culture and Sensitivity

Bacterial urine culture with antimicrobial susceptibility testing is the gold standard for confirming a bacterial UTI and guiding therapy [1][2][3]. Urine should ideally be collected by cystocentesis to minimize contamination [1]. A positive culture from a cystocentesis sample supports bacterial infection; however, it does not on its own localize infection to the upper urinary tract. Quantitative thresholds of ≥1,000 CFU/mL from cystocentesis samples are considered significant in cats [1][3].

Urinalysis

Urine sediment examination typically reveals pyuria (increased white blood cells in urine), bacteriuria, and hematuria [1][2]. Proteinuria may be present. Critically, impaired renal concentrating ability (isosthenuria or poorly concentrated urine, specific gravity < 1.035 in cats) is an important finding suggesting renal parenchymal involvement and distinguishing upper from lower UTI [2][3].

Hematology and Serum Biochemistry

Key laboratory abnormalities include:

Imaging

• ·Abdominal radiography may reveal renomegaly, nephrolithiasis, or ureterolithiasis contributing to urinary stasis [2].
• ·Abdominal ultrasonography is the preferred imaging modality and may demonstrate renal pelvic dilation (pyelectasis), increased echogenicity of the renal parenchyma, loss of corticomedullary distinction, perirenal effusion, or accumulation of echogenic material within the renal pelvis [1][2]. Ultrasonographic findings, while supportive, are not universally present in all cases.
• ·Intravenous pyelography or computed tomography (CT) may be employed in complex cases to further characterize structural abnormalities or obstructions.

Renal Pelvis Culture

In equivocal cases, culture of urine obtained directly from the renal pelvis via ultrasound-guided pyelocentesis provides definitive localization of infection to the upper urinary tract, though this is an invasive procedure reserved for complex or non-responsive cases [1][2].

Antimicrobial Therapy

Antimicrobial treatment is the cornerstone of pyelonephritis management and should be based on urine culture and susceptibility results whenever possible [1][2]. Empirical therapy may be initiated while awaiting culture results in clinically ill cats, but should be de-escalated or adjusted based on sensitivity data [1].

• ·Empirical therapy: Fluoroquinolones (e.g., marbofloxacin, enrofloxacin) are commonly used as first-line empirical treatment for suspected pyelonephritis due to their excellent gram-negative spectrum and high renal tissue penetration [1][2]. However, the ISCAID guidelines caution against routine empirical fluoroquinolone use without culture data due to resistance concerns [1].
• ·Duration of therapy: The ISCAID guidelines recommend a minimum of 4 weeks of antimicrobial therapy for pyelonephritis in dogs and cats, substantially longer than treatment durations used for uncomplicated lower UTIs [1]. This extended duration is necessary to ensure adequate penetration into renal parenchyma and to prevent relapse.
• ·Culture-guided adjustments: Following receipt of susceptibility results, the antibiotic should be narrowed to the most appropriate, narrowest-spectrum effective agent [1][3].
• ·Re-culture: Urine culture should be repeated 5–7 days after initiating therapy (to confirm treatment efficacy) and again 7 days after completing the antibiotic course to confirm bacteriological cure [1].
• ·Recurrent infections: If pyelonephritis recurs, investigation for underlying predisposing factors (e.g., urolithiasis, anatomical abnormalities, immunosuppression) is essential before initiating another prolonged antibiotic course [1][3].

Supportive and Fluid Therapy

• ·Intravenous (IV) fluid therapy is indicated in cats presenting with dehydration, azotemia, systemic illness, or sepsis; it supports renal perfusion, promotes diuresis to flush the infected urinary tract, and corrects electrolyte imbalances [2][4].
• ·Electrolyte correction: Hypokalemia should be supplemented (IV or oral potassium gluconate/chloride); hyperphosphatemia managed with phosphate binders in cats with concurrent CKD.
• ·Anti-nausea therapy: Maropitant or ondansetron for management of nausea and vomiting.
• ·Nutritional support: Appetite stimulants (e.g., mirtazapine) or assisted feeding in anorexic cats.
• ·Pain management: Analgesic agents appropriate for cats with renal compromise (cautious use of buprenorphine; NSAIDs are generally contraindicated in azotemic cats).

Management of Underlying Conditions

Concurrent conditions such as urolithiasis, ureteral obstruction, diabetes mellitus, or immunosuppression must be identified and managed, as they perpetuate infection and impair recovery [1][2][3]. Ureteral obstructions may require interventional procedures (ureteral stent placement or subcutaneous ureteral bypass [SUB] device).

The prognosis for feline pyelonephritis is highly variable and depends on the acuity of presentation, the degree of renal compromise at diagnosis, response to antimicrobial therapy, and presence of underlying comorbidities [1][2][4].

Acute Pyelonephritis Without Pre-existing Renal Disease

Cats with acute pyelonephritis who are diagnosed promptly and receive appropriate, culture-guided antimicrobial therapy for a full 4-week course generally carry a favorable short-term prognosis [1][2]. Renal function may recover substantially if infection is eliminated before extensive parenchymal damage occurs.

Acute-on-Chronic Kidney Disease (ACKD)

When pyelonephritis acts as an acute decompensating event in cats with pre-existing CKD, the prognosis worsens considerably. In a retrospective cohort study of 100 cats with ACKD (in which pyelonephritis was among the identified etiologies), short-term survival and long-term outcomes were significantly influenced by the degree of azotemia and underlying renal reserve at presentation [4]. Cats surviving to discharge faced ongoing risks of progressive CKD, recurrent infections, and further acute decompensation events [4].

Chronic / Recurrent Pyelonephritis

Recurrent or chronic pyelonephritis carries a guarded to poor long-term prognosis because each infectious episode contributes cumulatively to interstitial fibrosis and nephron loss, accelerating the progression toward end-stage CKD [1][2]. Cats with recurrent UTI and documented renal involvement require long-term monitoring of renal function parameters (creatinine, SDMA, urine specific gravity, urine protein:creatinine ratio) [1][3].

Prognostic Indicators

Clinically, poorer prognosis is associated with:

• ·Markedly elevated serum creatinine or BUN at presentation
• ·Non-regenerative anemia (low HCT) indicating chronicity
• ·Severe hypoalbuminemia
• ·Failure to identify or correct underlying predisposing causes
• ·Multi-drug resistant organisms on culture
• ·Presence of concurrent systemic disease (diabetes mellitus, FIV, immunosuppression)

Limitation Note: The available literature does not provide explicit, disease-specific case-fatality percentage figures exclusively for feline pyelonephritis as a standalone condition. The cited references describe survival trends in broader feline renal disease cohorts or provide clinical guideline recommendations rather than precise mortality statistics specific to this diagnosis alone [1][2][3][4].

While not all cases of feline pyelonephritis are preventable, several strategies reduce risk and minimize recurrence:

• ·Prompt treatment of lower UTIs: Early, culture-guided therapy for bacterial cystitis prevents ascending infection from reaching the upper urinary tract [1][3].
• ·Routine urinalysis and urine culture in high-risk cats: Cats with CKD, diabetes mellitus, or other immunocompromising conditions should have periodic urine culture (at least every 6 months) to detect subclinical bacteriuria before it progresses to clinical pyelonephritis [1][3].
• ·Management of urolithiasis: Dietary dissolution or surgical/interventional removal of uroliths eliminates a key structural predisposing factor for ascending infection and urinary stasis [2].
• ·Judicious use of urinary catheters: Urinary catheters should be placed and maintained with strict aseptic technique; indwelling catheters should be removed as soon as clinically feasible to minimize infection risk [1].
• ·Control of underlying diseases: Optimal glycemic control in diabetic cats and management of other immunosuppressive conditions reduces susceptibility to recurrent UTI and pyelonephritis [2][3].
• ·Antimicrobial stewardship: Avoiding inappropriate or subtherapeutic antibiotic use reduces selection pressure for resistant uropathogens that are more difficult to treat [1][3].
• ·Adequate hydration: Encouraging water intake through wet food diets, water fountains, or oral fluid supplementation promotes diuresis and reduces bacterial colonization of the urinary tract [2].
• ·Post-treatment surveillance: Following completion of antimicrobial therapy, re-culture of urine 7 days after course completion is recommended to confirm bacteriological cure and detect early relapse [1].
• ·No vaccine is currently available for the prevention of bacterial uropathogens causing feline pyelonephritis.